The Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) adopted positive opinions, recommending marketing authorizations, for Novo Nordisk's new insulin Tresiba and insulin Ryzodeg for the treatment of diabetes mellitus in adults.
Tresiba , the intended brand name for insulin degludec, is a new generation of once-daily basal insulin. In "treat-to-target? studies supporting the new drug application, where Tresiba was compared to insulin glargine,
I came home this morning at 7:00 after an early run. I walked with my son Tom to his bus stop, walked the dog and got ready for a shower. Before getting…
During the month leading up to November 14th, World Diabetes Day, you can participate in The Big Blue Test, one of the leading diabetes advocacy events of the year. When you take part in the Big Blue Test, not only do help yourself, you help others living with diabetes.